Biodelivery Sciences buy stratec
Start price
14.08.19
/
50%
€3.65
Target price
04.11.21
€7.00
Performance (%)
-18.90%
End price
05.11.21
€2.96
Summary
This prediction ended on 05.11.21 with a price of €2.96. The price of Biodelivery Sciences has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.90%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biodelivery Sciences | - | - | - | - |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by stratec for this prediction
In the thread Biodelivery Sciences
Buy Biodelivery Sciences
Kursziel gesetzt auf 5,0
The company continues to show impressive growth in BELBUCA scripts and sales. Recently acquired Symproic also seems to be off to a good start in the hand of BioDelivery as well. The company is on its way to achieving cash flow positive status by the close of this year. Selling at less than one times the eventual annual sales management believes it can achieve with BELBUCA and Symprioc, the shares remain cheap.
Kursziel geändert auf 7,0
In the thread Trading Biodelivery Sciences
Die von stratec gewählte maximale Laufzeit wurde überschritten